Contract Pharmaceutical News: Breaking Contract Pharmaceutical News, Comments and Articles.

Local CROs Unite for International Clinical Trials

SYDNEY, May 20, 2013 /PRNewswire/ -- Global CROs are no longer the obvious choice for companies looking to run international clinical trials. The motion is towards locally based CROs that are connected internationally to drive down R&D costs and leverage local know-how and quality.  An international team of locally entrenched contract research organizations (CROs) and specialist service...

The One World Doll Project Renews Contract With Former Mattel Sr. VP

HOUSTON, May 20, 2013 (GLOBE NEWSWIRE) -- The One World Doll Project, subsidiary of One World Holdings, Inc. (OTCBB:OWOO) announced that it has extended its executive consulting contract with Gene Insley, Former Sr. VP Engineering of all Girls Product at Mattel. "Upon the launch of this company we knew the guidance of a major toy company executive was going to be mandatory and as a former Sr. V...

Cashless Jail Payment Company Continental Prison Systems and Archonix Generate New Contract for Scott County, Missouri

IRVINE, Calif., May 20, 2013 (GLOBE NEWSWIRE) -- Continental Prison Systems, Inc. (OTC:CPSZ) - a payment processing technology company that specializes in the $500 billion government payment space, is pleased to announce that via its channel partner Archonix, it has signed the Scott County Jail in Missouri. Continental Prison Systems will provide inmate money load, bail, and debit card services v...

Diagnostic Imaging International Corp.: CTS Adds New Client Hospital

LAS VEGAS, NEVADA -- (Marketwired) -- 05/20/13 -- Diagnostic Imaging International Corp. (OTCQB: DIIG) announced today that its wholly-owned subsidiary, Canadian Teleradiology Services ("CTS"), has signed a new client hospital in Ontario, Canada. CTS has signed a three year contract with a new client hospital to provide teleradiology services. The contract was signed in April, at which time CTS...

Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder

A type of sleep apnea is now linked with teeth grinding, according to an April 9, 2013 article CNY Central (“Snoring and Teeth Grinding Could be a Sign of Sleep Disorder”). Woodland Hills dentist Dr. Kanani says that patients often don't realize that their sleep habits and stress levels can contribute to tooth damage. Los Angeles, California (PRWEB) May 19, 2013 Grinding your teeth at nig...

Cobra Biologics to manufacture DNA vaccine for Vaccibody

Clinical- and commercial-scale biologics and pharmaceuticals manufacturer, Cobra Biologics Ltd, and Vaccibody AS, a biotechnology company developing next-generation vaccines against cancer and chronic infections, have formed an agreement in which Cob...

DHS Holding, Co. Confirms LuckyFoxCasino.com

NASHVILLE, TN -- (Marketwired) -- 05/17/13 -- DHS Holding, Co. (PINKSHEETS: DHSM) has a wholly-owned subsidiary, Lucky Fox Casino, LTD, which operates out of Belize. Lucky Fox Casino, LTD signed a contract with FenServices to have LuckyFoxCasino.com developed and maintained. FenServices licensed software from SoftBet and other vendors that develop online casino gaming software. These vendors are...

Aeolus Strengthens Board of Directors With Oncology, Government Contracting and Financial Industry Veterans

MISSION VIEJO, CA -- (Marketwired) -- 05/17/13 -- Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel compounds to protect against radiological and chemical threats and for use in oncology, announced the appointment of John M. Clerici, Mitchell D. Kaye, and Jeffrey A. Scott, M.D., to its board of directors a...

US government awards antibody development contract to AnaptysBio

The US government has awarded a contract to AnaptysBio for the development of highly thermostable anti-ricin antibodies for biodefense applications.

RuiYi Signs On New Partners To Develop Anti-IL6 mAb In China

The China-U.S. hybrid signs on Shanghai-based Genor Biopharma in a co-development deal and contract manufacturer CMC Biologics to develop a cell line for RYI-008 for global manufacturing.

San Diego’s AnaptysBio Gets BioDefense Contract for Ricin Antibodies

AnaptysBio says today the U.S. government has asked the San Diego biotech to produce antibodies that counter the deadly effects of ricin and would not require refrigeration, so batches of anti-ricin antibodies could be stored at room temperatures. Un...

Diabetes Care Club Acquires Priority Diabetes Supply, Obtains CMS Contract to Distribute Diabetic Supplies

Leading provider of mail-order diabetic testing supplies becomes one of only 18 companies in nation authorized by CMS to serve Medicare patients Company also inks agreement with Roche to ensure continued delivery of its ACCU-CHEK line of products to Medicare population Diabetes Care Club, a leading provider o...

Kitware Develops a Customizable Simulation Framework to Provide HPC for Small to Mid-Sized Manufacturers

This Phase II project will lead to a customizable end-to-end simulation, visualization, and analysis infrastructure for supporting high performance computing operations. (PRWEB) May 16, 2013 Kitware, a leading provider of scientific R&D software solutions, today announces new Phase II SBIR funding from the U.S. Department of Energy for the continued development of an open-source, high perform...

Computer Sciences settles lawsuit over accounting for $97.5 mln

* Accounting issues raised over UK contract, Nordic region

NextPharma completes executive management team with the appointment of Jean Cuiné as Chief Scientific Officer

NextPharma Technologies Holding Limited, one of the leading contract manufacturers in Europe for the pharmaceutical, biotechnology and healthcare industries, is delighted to announce the appointment of Jean Cuiné to its executive management team. Dr Cuiné has joined NextPharma from Novartis where he held a number of senior roles in Chemistry Manufacturin...

Access Pharmaceuticals Reports First Quarter Results

DALLAS and NEW YORK, May 16, 2013 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, released its first quarter ended March 31, 2013 financial results.  The company indicated it will host a conference call at a later date to review financial results and ongoing commercial MuGard progress made within the quarter.  MuGard, Access' lead p...

Source BioScience Interim Management Statement

16th May 2013: Source BioScience plc (LSE: SBS), the international diagnostic and genetic analysis services business, today publishes its Interim Management Statement for the year to date. Unless otherwise stated, the financial information referenced below refers to the four months ended 30 April 2013, and the corresponding period last year, this being the latest practicable date to which f...

TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Recent Events

BETHESDA, Md., May 16, 2013 /PRNewswire/ -- TNI BioTech, Inc.,  (OTC PINK: TNIB), a biotech company combating fatal diseases through the activation and mobilization of the body's immune system using its patented immunotherapy, issued a letter to its shareholders from CEO Noreen Griffin and the company's board of directors. The letter follows: Dear Shareholders, The board of direct...

AnaptysBio Awarded U.S. Government Contract To Develop Anti-Ricin Antibodies

SAN DIEGO, May 16, 2013 /PRNewswire/ -- AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the receipt of a contract award from the U.S. government for the development of highly thermostable anti-ricin antibodies for biodefense applications.  Under the terms of AnaptysBio's contract with the Science and Technology Corporation, AnaptysBio will be responsible...

Bavarian Nordic - Interim Financial Report for the Period 1 January to 31 March 2013

KVISTGAARD, Denmark, May 16, 2013 - Bavarian Nordic A/S (OMX: BAVA) today publishes its first quarter 2013 results. Revenue for the period was DKK 206 million (2012: DKK 168 million) and the result before tax was a loss of DKK 41 million (2012: DKK 35 million loss). The Infectious Disease division remains profitable with an EBIT of DKK 38 million in the period (2012: DKK 47 million). After receiv...

New Study: Oral Sex Linked to Throat Cancer; polyDNA Recommends Gene-Eden-VIR against HPV, the Virus Associated with Throat Cancer

92.6% of patients with throat cancer also had an HPV infection, according to a new paper published in April, 2013 from the American Journal of Gastroenterology. (1) polyDNA suggests taking Gene-Eden-VIR to kill latent HPV in the throat. Rochester, NY (PRWEB) May 16, 2013 A new study shows more friends with benefits is not always better. The study found a link between the number of oral sex partne...

Nordion, Navidea sign contract manufacturing agreement

Nordion has entered into a contract manufacturing agreement with Navidea Biopharmaceuticals for NAV5001 a diagnostic imaging agent used to detect Parkinsonian Syndromes and Dementia with Lewy Bodies.

California Physician Groups Congratulate Marilyn Tavenner on Her Confirmation

California Association of Physician Groups: Statement from Donald CranePresident and CEOCalifornia Association of Physician Groups “The California Association of Physician Groups (CAPG) congratulates Marilyn Tavenner on her Senate Confirmation as CMS Administrator. CAPG and its members look forward to continuing to work with Ms. Tavenne...

Response Genetics, Inc. Announces Contract With Blue Shield of California

LOS ANGELES, May 16, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, today announced that it has entered into an agreement with health insurer Blue Shield of California to join all of Blue Shield of California's provider networks. The agreement...

DRC Reports Extension of Veterans Relationship Management Contract

ANDOVER, Mass., May 16, 2013 (GLOBE NEWSWIRE) -- Dynamics Research Corporation (Nasdaq:DRCO), a leading technology and management consulting company focused on driving performance, process and results for government clients, today reported that the Department of Veterans Affairs (VA), through the General Services Administration, has exercised the third option year of the Veterans Relationship Man...